Key Financial Data Of Group

COSMOS Pharmaceutical Corporation - Filing #7716268

Concept 2018-06-01 to
2018-11-30
2018-09-01 to
2018-11-30
As at
2018-11-30
As at
2018-05-31
2017-06-01 to
2018-05-31
As at
2017-11-30
2017-06-01 to
2017-11-30
2017-09-01 to
2017-11-30
Key financial data of group
Business results of group
Net sales
298,372,000,000 JPY
557,999,000,000 JPY
270,835,000,000 JPY
Ordinary profit (loss)
13,498,000,000 JPY
25,255,000,000 JPY
11,589,000,000 JPY
Profit (loss) attributable to owners of parent
9,005,000,000 JPY
17,633,000,000 JPY
7,781,000,000 JPY
Comprehensive income
9,016,000,000 JPY
17,617,000,000 JPY
7,790,000,000 JPY
Net assets
117,014,000,000 JPY
108,888,000,000 JPY
99,952,000,000 JPY
Total assets
255,035,000,000 JPY
250,609,000,000 JPY
234,345,000,000 JPY
Basic earnings (loss) per share
454.83
208.10
890.59
393.00
158.71
Diluted earnings per share
Equity-to-asset ratio
0.459 xbrli:pure
0.434 xbrli:pure
0.427 xbrli:pure
Net cash provided by (used in) operating activities
10,044,000,000 JPY
32,586,000,000 JPY
11,683,000,000 JPY
Net cash provided by (used in) investing activities
-14,501,000,000 JPY
-30,458,000,000 JPY
-14,173,000,000 JPY
Net cash provided by (used in) financing activities
-3,841,000,000 JPY
-8,188,000,000 JPY
-4,075,000,000 JPY
Cash and cash equivalents
13,369,000,000 JPY
21,668,000,000 JPY
21,162,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.